4,4-Diisothiocyanatostilbene Disulfonic Acid Enhanced 15-Deoxy-Δ12,14-prostaglandin J2-Induced Neuronal Apoptosis

被引:3
|
作者
Koma, Hiromi [1 ]
Yamamoto, Yasuhiro [1 ]
Kumagai, Hiroaki [1 ]
Yagami, Tatsurou [1 ]
机构
[1] HDU, Fac Pharmaceut Sci, Dept Pharmaceut Hlth Care, Div Physiol, 7-2-1 Kami Ohno, Himeji, Hyogo 6708524, Japan
关键词
primary cortical neuron; 15-deoxy-Delta(12,14)-prostaglandin J(2); apoptosis; 4,4-diisothiocyanatostilbene disulfonic acid; voltage-dependent anion channel; ACTIVATED RECEPTOR-GAMMA; RENAL-CELL CARCINOMA; POSSIBLE INVOLVEMENT; CORTICAL-NEURONS; PLASMA-MEMBRANE; J(2); CHANNEL; DEATH; DIDS; PROSTAGLANDIN-D2;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
4,4-Diisothiocyanatostilbene disulfonic acid (DIDS), an antagonist of anion channel including voltage-dependent anion channel (VDAC), acts as both neurotoxicant and neuroprotectant, resulting in the controversy. VDAC contributes to neuronal apoptosis and is a candidate target protein of 15-deoxy-Delta(12,14)-prostaglandin J(2) (15d-PGJ(2)). Caspase-3 is activated during neuronal apoptosis caused by 15d-PGJ(2). In the present study, we ascertained whether DIDS was neuroprotective or neurotoxic in the primary culture of rat cortical neurons. Neuronal cell viabilities were primarily evaluated by the 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H tetrazolium bromide (MTT) reduction assay. Plasma membrane integrity and apoptosis were detected by the staining of propidium iodide (PI) and Hoechst33342, respectively. Alternatively, apoptosis was also measured by caspase-3 assay kit. DIDS did not prevent neurons from undergoing the 15d-PGJ(2)-induced apoptosis. In contrast, DIDS caused neuronal cell death in a concentration-dependent manner by itself, confirming its neurotoxicity. The sublethal application of DIDS did not decrease MTT-reducing activity, increase caspase-3 activity, condense chromatin, allow PI to enter neuron and degenerate neuronal morphology significantly. Interestingly, DIDS enhanced the 15d-PGJ(2)-induced neuronal apoptosis markedly under the sublethal condition. To our knowledge, this is the first report of synergistic effects of DIDS on the neurotoxicity of 15d-PGJ(2).
引用
收藏
页码:1913 / 1920
页数:8
相关论文
共 50 条
  • [41] 15-deoxy-Δ12,14-prostaglandin J2, a ligand for peroxisome proliferators-activated receptor-γ, induces apoptosis in human hepatoma cells
    Date, M
    Fukuchi, K
    Morita, S
    Takahashi, H
    Ohura, K
    LIVER INTERNATIONAL, 2003, 23 (06): : 460 - 466
  • [42] Nonenzymatic free radical-catalyzed generation of 15-deoxy-Δ12,14-prostaglandin J2-like compounds (deoxy-J2-isoprostanes) in vivo
    Hardy, Klarissa D.
    Cox, Brian E.
    Milne, Ginger L.
    Yin, Huiyong
    Roberts, L. Jackson, II
    JOURNAL OF LIPID RESEARCH, 2011, 52 (01) : 113 - 124
  • [43] 15-Deoxy-Δ12,14-Prostaglandin J2 Inhibits Osteolytic Breast Cancer Bone Metastasis and Estrogen Deficiency-Induced Bone Loss
    Kim, Ki Rim
    Kim, Hyun Jeong
    Lee, Sun Kyoung
    Ma, Gwang Taek
    Park, Kwang Kyun
    Chung, Won Yoon
    PLOS ONE, 2015, 10 (04):
  • [44] 15-Deoxy-Δ-12,14-prostaglandin J2 effects in vascular smooth muscle cells: Implications in vascular smooth muscle cell proliferation and contractility
    Eguez, Carl
    Clark, Michelle A.
    O'Connor, Ann Tenneil
    PROSTAGLANDINS & OTHER LIPID MEDIATORS, 2021, 156
  • [45] Effects of 15-Deoxy-Δ12,14-Prostaglandin J2 (15d-PGJ2) and Rosiglitazone on Human Vδ2+ T Cells
    Li, Haishan
    Pauza, C. David
    PLOS ONE, 2009, 4 (11):
  • [46] 15-Deoxy-Δ12,14-prostaglandin J2 Exerts Antioxidant Effects While Exacerbating Inflammation in Mice Subjected to Ureteral Obstruction
    Nilsson, Line
    Palm, Fredrik
    Norregaard, Rikke
    MEDIATORS OF INFLAMMATION, 2017, 2017
  • [47] 15-Deoxy-Δ12,14-prostaglandin J2, an electrophilic lipid mediator of anti-inflammatory and pro-resolving signaling
    Surh, Young-Joon
    Na, Hye-Kyung
    Park, Jong-Min
    Lee, Ha-Na
    Kim, Wonki
    Yoon, In-Soo
    Kim, Dae-Duk
    BIOCHEMICAL PHARMACOLOGY, 2011, 82 (10) : 1335 - 1351
  • [48] STAT3 as a Potential Target for Tumor Suppressive Effects of 15-Deoxy-Δ12,14-prostaglandin J2 in Triple Negative Breast Cancer
    Kim, Su-Jung
    Cho, Nam-Chul
    Hahn, Young-Il
    Kim, Seong Hoon
    Fang, Xizhu
    Surh, Young-Joon
    JOURNAL OF CANCER PREVENTION, 2021, 26 (03) : 207 - 217
  • [49] 15-Deoxy-Δ12,14-prostaglandin J2 prevents inflammatory response and endothelial cell damage in rats with acute obstructive cholangitis
    Watanabe, Katsutaka
    Yokoyama, Yukihiro
    Kokuryo, Toshio
    Kawai, Kiyotaka
    Kitagawa, Tomomi
    Seki, Takashi
    Nakagawa, Akifumi
    Nagino, Masato
    AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 2010, 298 (03): : G410 - G418
  • [50] 15-Deoxy-Δ12,14-prostaglandin J2 as a potential regulator of bone metabolism via PPARγ-dependent and independent pathways: a review
    Xiong, Zhencheng
    Luo, Pan
    Zhou, Jun
    Tan, Mingsheng
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2019, 13 : 1879 - 1888